BioCentury | Mar 18, 2021
Deals
Led by ex-Springworks exec, Pyxis forges deal to gain access to Pfizer’s ADCs, platform tech
Pyxis CEO Lara Sullivan has struck a deal with her former employer, Pfizer, that adds two preclinical therapies to the biotech’s pipeline as well as a license to the pharma’s ADC platform to develop more programs....